These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 1469630

  • 1. Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor.
    Monnet FP, Debonnel G, Fournier A, de Montigny C.
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1219-25. PubMed ID: 1469630
    [Abstract] [Full Text] [Related]

  • 2. The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin.
    Monnet FP, Debonnel G, Bergeron R, Gronier B, de Montigny C.
    Br J Pharmacol; 1994 Jun; 112(2):709-15. PubMed ID: 8075892
    [Abstract] [Full Text] [Related]

  • 3. Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor.
    Monnet FP, Fournier A, Debonnel G, de Montigny C.
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1212-8. PubMed ID: 1469629
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of sigma ligands on the N-methyl-D-aspartate response in the CA1 and CA3 regions of the dorsal hippocampus: effect of mossy fiber lesioning.
    Debonnel G, Bergeron R, Monnet FP, De Montigny C.
    Neuroscience; 1996 Apr; 71(4):977-87. PubMed ID: 8684626
    [Abstract] [Full Text] [Related]

  • 5. Effect of short-term and long-term treatments with sigma ligands on the N-methyl-D-aspartate response in the CA3 region of the rat dorsal hippocampus.
    Bergeron R, de Montigny C, Debonnel G.
    Br J Pharmacol; 1997 Apr; 120(7):1351-9. PubMed ID: 9105712
    [Abstract] [Full Text] [Related]

  • 6. Modulation by sigma ligands of N-methyl-D-aspartate-induced [3H]noradrenaline release in the rat hippocampus: G-protein dependency.
    Monnet FP, Blier P, Debonnel G, de Montigny C.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):32-9. PubMed ID: 1407002
    [Abstract] [Full Text] [Related]

  • 7. Differential modulation of NMDA-stimulated [3H]dopamine release from rat striatum by neuropeptide Y and sigma receptor ligands.
    Ault DT, Werling LL.
    Brain Res; 1997 Jun 20; 760(1-2):210-7. PubMed ID: 9237537
    [Abstract] [Full Text] [Related]

  • 8. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors.
    Bergeron R, de Montigny C, Debonnel G.
    J Neurosci; 1996 Feb 01; 16(3):1193-202. PubMed ID: 8558248
    [Abstract] [Full Text] [Related]

  • 9. Electrophysiological evidence for the implication of cholecystokinin in the modulation of the N-methyl-D-aspartate response by sigma ligands in the rat CA3 dorsal hippocampus.
    Gronier B, Debonnel G.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar 01; 353(4):382-90. PubMed ID: 8935704
    [Abstract] [Full Text] [Related]

  • 10. The cytochromes P-450 are not involved in the modulation of the N-methyl-D-aspartate response by sigma ligands in the rat CA3 dorsal hippocampus.
    Monnet FP, Debonnel G, de Montigny C.
    Synapse; 1993 Jan 01; 13(1):30-8. PubMed ID: 8427011
    [Abstract] [Full Text] [Related]

  • 11. Effects of neuropeptide Y, peptide YY and sigma ligands on ion transport in mouse jejunum.
    Riviere PJ, Rao RK, Pascaud X, Junien JL, Porreca F.
    J Pharmacol Exp Ther; 1993 Mar 01; 264(3):1268-74. PubMed ID: 8450462
    [Abstract] [Full Text] [Related]

  • 12. Potentiation by dehydroepiandrosterone of the neuronal response to N-methyl-D-aspartate in the CA3 region of the rat dorsal hippocampus: an effect mediated via sigma receptors.
    Debonnel G, Bergeron R, de Montigny C.
    J Endocrinol; 1996 Sep 01; 150 Suppl():S33-42. PubMed ID: 8943785
    [Abstract] [Full Text] [Related]

  • 13. Effects of low and high doses of selective sigma ligands: further evidence suggesting the existence of different subtypes of sigma receptors.
    Bergeron R, Debonnel G.
    Psychopharmacology (Berl); 1997 Feb 01; 129(3):215-24. PubMed ID: 9084059
    [Abstract] [Full Text] [Related]

  • 14. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
    Monnet FP, de Costa BR, Bowen WD.
    Br J Pharmacol; 1996 Sep 01; 119(1):65-72. PubMed ID: 8872358
    [Abstract] [Full Text] [Related]

  • 15. Lack of effects by sigma ligands on neuropeptide Y-induced G-protein activation in rat hippocampus and cerebellum.
    Hong W, Werling L.
    Brain Res; 2001 May 18; 901(1-2):208-18. PubMed ID: 11368969
    [Abstract] [Full Text] [Related]

  • 16. Modulation of [3H]Dopamine release from rat nucleus accumbens by neuropeptide Y may involve a sigma1-like receptor.
    Ault DT, Radeff JM, Werling LL.
    J Pharmacol Exp Ther; 1998 Feb 18; 284(2):553-60. PubMed ID: 9454797
    [Abstract] [Full Text] [Related]

  • 17. Neuropeptide Y-mediated enhancement of NMDA-stimulated [3H]dopamine release from rat prefrontal cortex is reversed by sigma1 receptor antagonists.
    Ault DT, Werling LL.
    Schizophr Res; 1998 May 04; 31(1):27-36. PubMed ID: 9633834
    [Abstract] [Full Text] [Related]

  • 18. In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands.
    Monnet FP, Debonnel G, de Montigny C.
    J Pharmacol Exp Ther; 1992 Apr 04; 261(1):123-30. PubMed ID: 1532832
    [Abstract] [Full Text] [Related]

  • 19. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems.
    Gronier B, Debonnel G.
    Eur J Pharmacol; 1999 Mar 05; 368(2-3):183-96. PubMed ID: 10193654
    [Abstract] [Full Text] [Related]

  • 20. Evidence for in vivo interactions between neuropeptide Y-related peptides and sigma receptors in the mouse hippocampal formation.
    Bouchard P, Dumont Y, Fournier A, St-Pierre S, Quirion R.
    J Neurosci; 1993 Sep 05; 13(9):3926-31. PubMed ID: 8366352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.